Oral supplementation with L-homoarginine in young volunteers

Low blood concentrations of the naturally occurring amino acid L-homoarginine (L-hArg) are related to impaired cardiovascular outcome and mortality in humans and animals. L-hArg is a weak substrate of nitric oxide synthase and an inhibitor of arginases in vitro. The aim of our study was to obtain kinetic and dynamic data after oral L-hArg supplementation.


Published in:
British journal of clinical pharmacology, 82, 6, 1477-1485
Year:
2016
Publisher:
Wiley-Blackwell
ISSN:
1365-2125
Laboratories:




 Record created 2016-12-23, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)